fbpx Implications of the revival of therapeutic research on psychedelic drugs | NDARC - National Drug and Alcohol Research Centre

Implications of the revival of therapeutic research on psychedelic drugs

Emeritus Professor Wayne Hall
Resource Type: NDARC Seminars

Emeritus Professor Wayne Hall presented at the NDARC Webinar Series on Thursday 21 July 2022.

This webinar explored factors that explain the revival of interest in the therapeutic use of psychedelic drugs.

The presentation addressed the following questions: What factors have contributed to renewed research interest in psychedelic drugs? How does the recent research relate to earlier psychedelic research? What research studies have been done and what have they shown? How should we regulate the clinical use of psychedelic drugs to treat addiction and mental disorders? Should we allow the nonmedical use of psychedelic drugs by adults?


About the speaker

Wayne Hall is Emeritus Professor at the National Centre for Youth Substance Use Research at the University of Queensland and the Queensland Alliance for Environmental Health Sciences. He was: a Professor at the National Addiction Centre, Kings College London (2014-2019); Director of Centre for Youth Substance Abuse Research (2014-2016), NHMRC Australia Fellow (2009-2014), Professor of Public Health Policy, School of Population Health (2005-2009), Director of the Office of Public Policy and Ethics, Institute for Molecular Bioscience (2001-2005) and Executive Director of the National Drug and Alcohol Research Centre (1994-2001). He has advised the World Health Organization on the health effects of cannabis use; drug substitution treatment; the global burden of disease; and the ethical implications of genetic and neuroscience research on addiction.

Emeritus Professor Hall's NDARC monograph 'The 21st Century Revival of Therapeutic Research on Classic Psychedelic Drugs: Antecedents, Evidence and Potential Future Medical and other Uses' is available in full here.